Deep Vein Thrombosis
Cardiovascular
Deep Vein Thrombosis is treated with 6 medications in our database, including Enoxaparin Sodium, Enoxaparin sodium, Fragmin, Lovenox, ENOXAPARIN SODIUM, and 1 more. 5 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Sanofi, Pfizer, GlaxoSmithKline. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Deep Vein Thrombosis treatment below.
What help exists for Deep Vein Thrombosis
13
drugs indexed
10
with copay cards
10
with patient assistance
1
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Deep Vein Thrombosis
13 totalLovenox
enoxaparin sodium Β· Sanofi
ππPradaxa
dabigatran etexilate Β· Boehringer Ingelheim
ππSAVAYSA
EDOXABAN TOSYLATE Β· Daiichi Sankyo
DABIGATRAN ETEXILATE
dabigatran etexilate Β· Boehringer Ingelheim
ππEnoxiluv Kit
Enoxaparin Sodium, Isopropyl Alcohol Β· Method
XARELTO
rivaroxaban Β· Janssen
ππDABIGATRAN
Dabigatran Β· Boehringer Ingelheim
ππFondaparinux Sodium
Fondaparinux Sodium Β· Mylan
Enoxaparin Sodium
enoxaparin sodium Β· Sanofi
ππArixtra
fondaparinux sodium Β· Mylan
ππApixaban
APIXABAN
ππELIQUIS
apixaban
ππFragmin
Dalteparin Sodium Β· Pfizer
ππ
π = copay card Β· π = patient assistance program
Prior authorization patterns for Deep Vein Thrombosis drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
Showing 10 of 21 PA rules for Deep Vein Thrombosis drugs. View individual drug pages for complete PA detail.